ENXTAM:DSFIRChemicals
How Investors Are Reacting To DSM-Firmenich (ENXTAM:DSFIR) €540 Million Share Buyback And Capital Reduction
On March 12, 2026, DSM-Firmenich AG announced a share repurchase program of up to €540 million, with €500 million earmarked for capital reduction and €40 million to satisfy share-based compensation, to be executed by a mandated bank and targeted for completion by the end of Q3 2026.
This sizable buyback authorization signals the Board’s willingness to return cash to investors while tightening the share count, which can meaningfully influence ownership dilution from employee equity plans and...